{"nct_id":"NCT02858440","title":"A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia","status":"COMPLETED","status_verified_date":"2019-09","start_date":"2016-09-13","start_date_type":"ACTUAL","primary_completion_date":"2017-10-24","primary_completion_date_type":"ACTUAL","completion_date":"2018-11-13","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}